Error: Could not add to watchlist. X
+ Watchlist

Immuron Ltd

IMRN:US
NASDAQ CM
8.65
USD
0.34
4.09%
As of 8:10 PM EDT 6/23/2017
Open
8.48
Day Range
8.29 - 8.68
Volume
28,978
Previous Close
8.31
52Wk Range
7.66 - 16.34
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
8.48
Day Range
8.29 - 8.68
Volume
28,978
Previous Close
8.31
52Wk Range
7.66 - 16.34
Current P/E Ratio (TTM)
-
Earnings per Share (AUD) (TTM)
-
Market Cap (m USD)
28.121
Shares Outstanding (m)
3.251
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
-0.09%
% Price Change
-0.13%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Immuron Limited operates as a biopharmaceutical company. The Company focuses on oral immunotherapy utilizing polyclonal antibody products that target the human gut immune system and gut microbiome. Immuron's technology platform is developing and producing an orally stable therapeutic for various immune mediated and inflammatory disorders.
Address
1233 High Street
Suite 1
Armadale, VIC 3143
Australia
Phone
61-3-9824-5254
  • Peter Anastasiou
    Vice Chairman
  • Thomas Liquard
    Chief Executive Officer
  • Peter Vaughan
    Co-CFO/Joint Secretary
  • Phillip Hains
    Co-CFO/Joint Secretary
  • Jerry Kanellos
    Chief Operating & Scientific Officer
Show More